The Mode of Action of Colloidal Bismuth Subcitrate

References

• Chambers T K. Practical lectures on the management of the digestion in disease. Lecture V on diarrhoea. Lancet 1857; 2: 185–187
   Google Scholar
• Mark G., Beatty W K. The precious metals of medicine. Charles Scribner, New York 1920
   Google Scholar
• DuPont H L, Ericsson C D, Johnson P C, Bitsura J M, De Pont M W, de la Cabala F J. Prevention of traveller's diarrhea by the tablet formulation of bismuth subsalicylate. JAMA 1987; 257: 1347–1350
   PubMed Web of Science ®Google Scholar
• Wagstaff A J, Benfield P, Monk J P. Colloidal bismuth subcitrate: a review of its pharmaco-dynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease. Drugs 1988; 36: 132–157
   PubMed Web of Science ®Google Scholar
• Wieriks J, Hespe W, Jaitly K D, Koekkoek P H, Lavy U. Pharmacological properties of colloidal bismuth subcitrate (CBS, De-Nol). Scand J Gastro-enterol 1982; 17(suppl 80)11–16
   PubMedGoogle Scholar
• Konturek S J, Radecki T, Piastucki I, Drodzdwicz D. Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate. Digestion 1987; 37(suppl 2)F-15
   PubMedGoogle Scholar
• Soldani G, Del Tacca M, Bernardini C, et al. Gastric pharmacological activities of tripotassium dicitrato bismuthate in rats and dogs. Pharmacol Res Commun 1985; 17: 1017–1026
   PubMedGoogle Scholar
• Flavell Matts S G, Swan C HJ. Initial evaluation of a new bismuth compound in the therapy of peptic ulcer with in vivo gastric analysis. Postgrad Med J 1965; 41: 109–114
   PubMed Web of Science ®Google Scholar
• Baron J H, Barr J, Batten J, Sidebotham R S, Dencer J. Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol). Gut 1986; 27: 486–490
   PubMed Web of Science ®Google Scholar
• Roberts N B, Taylor W H. The effect of tripotassium dicitrato bismuthate (De-Nol) upon the individual human pepsins [Abstract]. Scand J Gastroenterol 1982; 17(suppl 78)114
   Google Scholar
• Stiel D, Peters T J. Tripotassium dicitrato bismuthate (De-Nol) binds conjugated bile acids in vitro. A possible mechanism in gastric ulcer healing [Abstract]. Proc Aust SOC Med Res 1983; 16: 18A
   Google Scholar
• Moshal M G, Gregory M A, Pillay C, Spitaels J M. Does the duodenal cell ever return to normal? A comparison between treatment with cimetidine and De-Nol. Scand J Gastroenterol 1979; 14(suppl 54)48–51
   Google Scholar
• Knapiak Z, Lubozynska-Kowalska W, Paradowski L, Ceglarski Z. Action of colloidal bismuth subcitrate on gastric juice [Abstract]. XII International Congress of Gastroenterology, Lisbon, 1984, A864
   Google Scholar
• Guslandi M. Evaluation of gastric mucus in man by means of the ‘mucoprotective index’. A review of a five year experience with this method. Methods Find Exp Clin Pharmacol 1983; 5: 735–739
   PubMed Web of Science ®Google Scholar
• Hollanders D, Morrissey S M, Mehta J. Mucus secretion in gastric ulcer patients treated with tripotassium dicitrato bismuthate (De-Nol). Br J Clin Pract 1983; 37: 112–114
   PubMedGoogle Scholar
• Slomiany B L, Sarosiek J, Bilski J, Slomiany A. Evidence for proteolytic disruption of gastric mucus coat by Campylobacter pylori. S Afr Med J 1988; 74(suppl)40–41
   PubMedGoogle Scholar
• Tasman-Jones C, Maher C, Thomsen L, Lee S P, Vanderwee M. Mucosal defences and gastroduodenal disease. Digestion 1987; 37(suppl 2)1–7
   PubMedGoogle Scholar
• Goggin P M, Marrero J M, Jarawi R P, Corbishley C M, Yu C W, Northfield T C. Effect of Helicobacter pylori infection on gastric mucosal hydrophobicity in man [Abstract]. Gastroenterology 1990; 98: 49
   Google Scholar
• O'Morain C, Mathai E, Daw M, Cafferty M, Keane C, O'Moore R. Lipolytic activity of Helicobacter pylori (HP) [Abstract]. Gastroenterology 1990; 98: 49
   Google Scholar
• Weiss G, Kallmeyer J C. Pilot trial of a colloidal bismuth preparation in the treatment of peptic ulcer. S Afr Med J 1968; 42: 317–320
   PubMedGoogle Scholar
• Lanza F L. An endoscopic evaluation of gastric ulcer treated with a mixture containing bismuth ammonium citrate. Curr Ther Res 1970; 12: 779–778
   PubMed Web of Science ®Google Scholar
• Lam S K, Koo J, Cheng C H, Ho J, Ong G B. Treatment of corpus and prepyloric gastric ulcers with tripotassium dicitrato bismuthate (De-Nol) [Abstract]. Gastroenterology 1981; 80: 1202A
   Web of Science ®Google Scholar
• Lee S P. A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid. Scand J Gastroenterol 1982; 17(suppl 80)17–21
   PubMed Web of Science ®Google Scholar
• Koo J, Ho J, Lam S K, Wong J, Ong G B. Selective ccating of gastric ulcer by tripotassium dicitrato bismuthate in the rat. Gastroenterology 1982; 82: 864–870
   PubMed Web of Science ®Google Scholar
• Lambert J R, King R G, Way D J, Korman M G, Hansky J. Accumulation of bismuth in gastric mucosa after DeNol therapy—fact or fiction [Abstract]. Gastroenterology 1989; 96: A284
   Google Scholar
• Konturek S J, Radecki T, Piastucki I, Brzozowski T, Drozdowicz D. Gastroprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins. Gut 1987; 28: 201–205
   PubMed Web of Science ®Google Scholar
• Malandrino S, Bestetti A, Fumagalli G, Borsa M, Vigano T, Tonon G. Role of endogenous prostaglandins in protection of rat gastric mucosa by tripotassium dicitrate bismuthate. Scand J Gastroenterol 1987; 22: 943–948
   PubMed Web of Science ®Google Scholar
• Hall D W, Van Den Hoven W E. Gastric mucosal protection and prostaglandin E2 generation in rats by colloidal bismuth subcitrate (De-Nol). Arch Int Pharmacodyn Ther 1987; 286: 308–319
   PubMedGoogle Scholar
• Estela R, Feller A, Backhouse C, Castro R, Ugarte G. Effectos del subcitrato de bismuto coloidal e hidroxido de aluminio sobre 10s niveles gastricos y duodenales de prostaglandina E2. Rev Med Chile 1984; 112: 975–981
   PubMedGoogle Scholar
• Konturek S J, Kwiecien N, Obtulowicz W, Hebzda Z, Oleski J. Effects of protective drugs on gastric alkaline secretion in man. Scand J Gastroenterol 1987; 22: 1059–1063
   PubMed Web of Science ®Google Scholar
• Pugh S, Williams S E, Barton T, Clark C G, Lewis M R. Endogenous prostaglandin E2 synthesis preserved following cytoprotection by Rotor (bismuth subnitrate) in the rat alcohol model of gastric ulceration. Br J Exp Pathol 1988; 69: 833–838
   PubMedGoogle Scholar
• Crampton J R, Gibbons L C, Rees D W. Effect of certain ulcer-healing agents on amphibian gastro-duodenal bicarbonate secretion. Scand J Gastroenterol 1986; 21(suppl 125)113–116
   Google Scholar
• Konturek S J, Bilski J, Kwiecien N, et al. De-Nol stimulates gastric and duodenal alkatine secretion through prostaglandin dependent mechanism. Gut 1987; 28: 1557–1563
   PubMed Web of Science ®Google Scholar
• Sherrock C J, Crampton J R, Gibbons L C, Rees D W. Effect of bismuth subcitrate on amphibian gastroduodenal bicarbonate secretion. Gut 1989; 30: 917–921
   PubMed Web of Science ®Google Scholar
• McLean A J, Froomes F, Wan A T. Biliary handling of bismuth subcitrate in man. Clin Pharmacol Ther 1989; 45: 150
   Web of Science ®Google Scholar
• Konturek S J, Dembinski A, Warzecha Z, Bielanski W, Brzozowski T, Drozolowicz D. Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats. Gut 1988; 29: 894–902
   PubMed Web of Science ®Google Scholar
• Dupont L. Bismuth subsalicylate in the treatment and prevention of diarrheal disease. Drug Intell Clin Pharm 1987; 21: 687–693
   PubMedGoogle Scholar
• Lambert J R, Mégraud F, Geraud G, et al. Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents. Antimicrob Agents Chemother 1986; 30: 510–511
   PubMed Web of Science ®Google Scholar
• McNulty C AM, Dent J C, Wix R. Susceptibility of clinical isolates of Campylobacter pylori to 11 antimicrobial agents. Antimicrob Agents Chemother 1985; 28: 837–838
   PubMed Web of Science ®Google Scholar
• Goodwin C S, Blake P, Blumcow E. The minimum inhibitory concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. Antimicrob Agents Chemother 1986; 17: 309–314
   Google Scholar
• Goodwin C S, Armstrong J AQ, Marshall B J. Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol 1986; 39: 353–365
   PubMed Web of Science ®Google Scholar
• Dooley C P, Cohen H. The clinical significance of Campylobacter pylori. Ann Intern Med 1988; 108: 70–79
   PubMed Web of Science ®Google Scholar
• Graham D Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615–625
   PubMed Web of Science ®Google Scholar
• Armstrong J A, Wee S H, Goodwin C S, Wilson D H. Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro—an ultrastructural study. J Med Microbiol 1987; 24: 343–350
   PubMed Web of Science ®Google Scholar
• Marshall B J, Armstrong J A, Francis G J, Nokes N T, Wee S H. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion 1987; 37(suppl 2)1630
   Google Scholar
• Kamsteeg H, Poot L J, Van den Berg T P. Activity of colloidal bismuth subcitrate and other bismuth salts against the adhesive properties of Helicobacter pylori. Rev Esp Enf Digest 1990; 78(suppl l)119–120
   Google Scholar
• Sarosiek J, Bilski J, Murty V L, Slomiany A, Slomiany B L. Colloidal bismuth subcitrate (De-Nol) inhibits degradation of gastric mucin by Campylobacter pylori protease. Am J Gastroenterol 1989; 84: 506–510
   PubMed Web of Science ®Google Scholar
• Czinn S, Carr H, Yang P. Demonstration of a soluble phosphodiesterase, phospholipase C produced by Helicobacter pylori: a potential virulence factor [Abstract]. Gastroenterology 1990; 98: 34
   Google Scholar
• Lambert J R, Way D J, King R G, Wan A, McLean A J. Bismuth levels in the human gastric mucosa [Abstract]. Gastroenterology 1988; 95: A405
   Google Scholar
• Lambert J R, Way D J, King R G, Eaves E R, Lianeas K, Wan A. De-Nol vs. Pepto-Bismol: bismuth pharmacokinetics in the human gastric mucosa [Abstract]. Gastroenterology 1989; 96: A284
   Google Scholar
• McLean A J, Froomes F, McNeil J J, Wan A T, Harrison P M. Bismuth subcitrate handling in man [Abstract]. Clin Pharmacol Ther 1988; 43: 186
   Web of Science ®Google Scholar